Clinical Trial Update: Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma [Phase 1]

View source ↗

Summary

A Phase 1 trial combining partial brain radiotherapy, temozolomide, chloroquine, and tumor treating fields for newly diagnosed glioblastoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Aralen (chloroquine)
• Temodar (Temozolomide)
• Tumor Treating Fields therapy (tumor treating fields)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Glioblastoma, Gliosarcoma | Phase 1 | Status: TERMINATED